← Unilever overview

Unilever vs LOréal: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Unilever PLC (UNLYD)

Q3 2026
▲3

Unilever's food merger and strong Q2 volumes drive gains

  • Food merger with McCormick Unilever agreed to merge its food division (Hellmann's, Knorr) with McCormick for $45B, receiving $15.7B cash and a 9.9% stake, simplifying into a beauty and wellness company.

    This major strategic move reshapes Unilever and was a key driver of investor interest.

  • Record Q2 volume growth Q2 volumes rose 5.5%, the strongest in 16 years, prompting raised guidance and an 8% share rally.

    Strong operational performance directly boosted the stock price.

  • Thorne supplements bid concerns Unilever is exploring a $4B bid for Thorne supplements—a good strategic fit but pricey, with past deals like Dollar Shave Club disappointing, raising overpayment concerns.

    This potential acquisition could be positive but carries risks that may weigh on sentiment.

  • Regulatory and labor progress The UK regulator opened a consultation, and union agreements removed labor obstacles. The deal is expected to close by mid-2027.

    Reduced execution risk supports the merger's completion and investor confidence.

July 2026
▲3

Unilever's food merger and strong Q2 volumes drive gains

  • Food merger with McCormick Unilever agreed to merge its food division (Hellmann's, Knorr) with McCormick for $45B, receiving $15.7B cash and a 9.9% stake, simplifying into a beauty and wellness company.

    This major strategic move reshapes Unilever and was a key driver of investor interest.

  • Record Q2 volume growth Q2 volumes rose 5.5%, the strongest in 16 years, prompting raised guidance and an 8% share rally.

    Strong operational performance directly boosted the stock price.

  • Thorne supplements bid concerns Unilever is exploring a $4B bid for Thorne supplements—a good strategic fit but pricey, with past deals like Dollar Shave Club disappointing, raising overpayment concerns.

    This potential acquisition could be positive but carries risks that may weigh on sentiment.

  • Regulatory and labor progress The UK regulator opened a consultation, and union agreements removed labor obstacles. The deal is expected to close by mid-2027.

    Reduced execution risk supports the merger's completion and investor confidence.

Latest
▲4

Unilever surges on record volume growth and raised outlook

  • Strongest volume growth since 2010 lifts outlook Unilever reported its best quarterly volume growth in 16 years, with Q2 volumes up 5.5% and sales up 5.8%. Management raised full-year sales growth guidance to 4-6% from the bottom of that range. This shows customers are buying more products, not just paying higher prices, which is a healthier kind of growth and directly boosts profit expectations.

    This is the core new event that drove the stock's biggest jump in four years and answers why UNLYD is moving now.

  • Shares rally over 8% on results and guidance upgrade Unilever shares jumped more than 8% in London and US trading, the biggest daily gain in four years, after the strong results and raised outlook. The rally lifted the FTSE 100 and European consumer goods stocks. This price move reflects investors quickly repricing the company's growth prospects upward.

    It captures the immediate market reaction to the new earnings news, which is central to why the stock is moving right now.

  • UK regulator opens consultation on McCormick food deal The UK competition watchdog is inviting comments on McCormick's acquisition of Unilever's food business until August 5. The deal values the food arm at about $45 billion, with Unilever receiving $15.7 billion cash and a large stake in the combined company. Regulatory review is a normal step and does not block the value-unlocking sale.

    It is a new regulatory development in the ongoing food sale, which is a major driver of Unilever's transformation and share price.

  • Worker commitments agreed ahead of food sale completion Unilever agreed with European unions on job protections and consultation timelines for two years after the deal closes, expected by mid-2027. This removes a potential labor obstacle to the $44.8 billion sale. The deal will leave Unilever shareholders owning 55.1% of the enlarged group, with Unilever keeping a 9.9% stake and receiving $15.7 billion cash.

    It is a new step that de-risks the food sale, supporting the company's simplification and cash return story.

▲3

Unilever's $45B food sale and Thorne bid reshape its portfolio

  • Unilever to sell food division for $45B Unilever agreed to merge its food business (Hellmann's, Knorr) with McCormick in a $45 billion deal, receiving about $15.7 billion in cash. This simplifies Unilever into a beauty and wellness company and returns cash to shareholders, which supports the share price.

    This is the biggest new event of the period and directly changes Unilever's business and finances.

  • Unilever eyes $4B Thorne supplements bid Unilever is exploring a $4 billion bid for Thorne, a fast-growing supplements brand. It fits the wellness push but is pricey, and past deals like Dollar Shave Club have disappointed. The market may worry about overpaying, so the effect is uncertain.

    This is a new potential acquisition that could shift Unilever's growth profile and capital allocation.

  • Record M&A backdrop boosts Unilever's deal Global M&A hit a record $2.6 trillion in the first half of 2026, and UK deal value is on track for a record year. Unilever's food sale is a top deal, and the strong market makes it more likely to complete on good terms.

    The broader deal boom increases confidence that Unilever's divestment will close successfully and at a good valuation.

  • Berkshire interest could ease deal financing Reports suggest Berkshire Hathaway, with nearly $400 billion in cash, could help finance McCormick's purchase of Unilever's food unit. That reduces the risk the deal stalls and supports the $45 billion valuation for Unilever's assets.

    A deep-pocketed backer lowers execution risk on the food sale, a key driver for Unilever's shares.

LOréal S.A. (OR.PA)

Q3 2026
▲3

L'Oréal gains on beauty shift, deals, and AI marketing

  • Strong H1 results and record margin H1 sales rose 6.5% like-for-like to €23.77bn with a record 21.3% operating margin, and Q2 beat expectations on haircare and mascara demand, showing resilient consumer appetite.

    This explains the fundamental strength that supported the stock during the period.

  • Strategic acquisitions and license wins L'Oréal secured the Gucci beauty license early, acquired Kering's beauty division for $4.7bn, Innovist and Onesto Labs, and is eyeing an Armani stake, expanding its brand portfolio.

    These deals are major strategic moves that could drive future growth and were new in the period.

  • Chinese consumers shift to premium beauty Chinese consumers are moving from luxury fashion to premium beauty, helping L'Oréal overtake LVMH as France's most valuable listed company, a significant market shift.

    This consumer trend directly boosted L'Oréal's relative valuation and market position.

  • AI marketing and bond raise, but risks remain AI now drives ~20% of marketing and a €2bn bond adds flexibility, but luxury missed forecasts, travel retail remains weak, and dealmaking plus the bond raise carry integration and leverage risks.

    This captures both the efficiency gains and the real counterweights that could pressure the stock.

September 2026
▲4

L'Oréal gains from China beauty shift, dealmaking and AI push

  • Chinese consumers shift to premium beauty Chinese shoppers are cutting back on luxury fashion but still buying premium skincare and cosmetics. L'Oréal's luxury beauty division in China grew 10% last quarter, and 37% of high-spending Chinese consumers plan to spend more on beauty next year. This supports demand for OR.PA.

    This is a core demand driver showing why L'Oréal is outperforming luxury peers in a key market.

  • L'Oréal becomes France's most valuable listed company L'Oréal overtook LVMH as France's most valuable listed company, helped by the 'lipstick effect' — when money is tight, people still treat themselves to affordable beauty items. L'Oréal shares are up about 5% this year while LVMH is down 35%, showing a clear investor preference for beauty over high fashion.

    This milestone reflects the market's recognition of L'Oréal's relative strength and the shift in consumer spending.

  • Dealmaking spree: Kering beauty, Onesto Labs, Armani stake L'Oréal bought Kering's beauty division for $4.7 billion, won approval to buy India's Onesto Labs, and is in talks for a minority stake in Giorgio Armani. These moves expand its luxury and consumer brands, deepen its fragrance and cosmetics reach, and add growth in India. They strengthen future earnings power.

    These deals are major capital actions that expand L'Oréal's portfolio and market reach, directly affecting its growth outlook.

  • AI-led marketing and €2bn bond for flexibility L'Oréal says nearly 20% of its marketing spend is now AI-led, improving efficiency and consumer targeting. It also priced a €2 billion bond to fund general corporate needs, giving it cheap, long-term money. Both support profit margins and future investments.

    These show operational efficiency gains and financial strength, which underpin the company's ability to grow and invest.

Latest
▲4

L'Oréal gains from China beauty shift, dealmaking and AI push

  • Chinese consumers shift to premium beauty Chinese shoppers are cutting back on luxury fashion but still buying premium skincare and cosmetics. L'Oréal's luxury beauty division in China grew 10% last quarter, and 37% of high-spending Chinese consumers plan to spend more on beauty next year. This supports demand for OR.PA.

    This is a core demand driver showing why L'Oréal is outperforming luxury peers in a key market.

  • L'Oréal becomes France's most valuable listed company L'Oréal overtook LVMH as France's most valuable listed company, helped by the 'lipstick effect' — when money is tight, people still treat themselves to affordable beauty items. L'Oréal shares are up about 5% this year while LVMH is down 35%, showing a clear investor preference for beauty over high fashion.

    This milestone reflects the market's recognition of L'Oréal's relative strength and the shift in consumer spending.

  • Dealmaking spree: Kering beauty, Onesto Labs, Armani stake L'Oréal bought Kering's beauty division for $4.7 billion, won approval to buy India's Onesto Labs, and is in talks for a minority stake in Giorgio Armani. These moves expand its luxury and consumer brands, deepen its fragrance and cosmetics reach, and add growth in India. They strengthen future earnings power.

    These deals are major capital actions that expand L'Oréal's portfolio and market reach, directly affecting its growth outlook.

  • AI-led marketing and €2bn bond for flexibility L'Oréal says nearly 20% of its marketing spend is now AI-led, improving efficiency and consumer targeting. It also priced a €2 billion bond to fund general corporate needs, giving it cheap, long-term money. Both support profit margins and future investments.

    These show operational efficiency gains and financial strength, which underpin the company's ability to grow and invest.

July 2026
▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

  • H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.

    This is the core earnings event that directly drives investor confidence and valuation.

  • Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.

    It confirms the growth trend and shows demand is holding up in key regions.

  • Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.

    It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.

  • Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.

    These deals show management actively deploying capital for future growth.

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

  • H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.

    This is the core earnings event that directly drives investor confidence and valuation.

  • Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.

    It confirms the growth trend and shows demand is holding up in key regions.

  • Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.

    It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.

  • Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.

    These deals show management actively deploying capital for future growth.